ReviewInternational journal of molecular sciences2019

Setting Fire to ESA and EMA Resistance: New Targeted Treatment Options in Lower Risk Myelodysplastic Syndromes.

Anne Sophie Kubasch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.